ESC Premium Access

Use of machine learning to determine stroke severity of patients diagnosed with stroke in claims data

Congress Presentation

About the speaker

Doctor Emily Kogan

Janssen Pharmaceutical Companies of Johnson and Johnson, Raritan (United States of America)
0 follower

6 more presentations in this session

Comparison of analysis methodologies for net outcome with edoxaban vs warfarin in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial

Speaker: Mrs R. Hamershock (Boston, US)


Safety and effectiveness of dabigatran relative to warfarin in routine care: final results from a long-term monitoring program

Speaker: Doctor K. Zint (Ingelheim, DE)


National prescribing and adverse event rates of patients at risk of stroke with non-valvular AF from CPRD linked database: does 'big data' reflect clinical trials and identify areas for improvement?

Speaker: Doctor V. Mehta (London, GB)


Comparison of long DAPT versus short DAPT in Japanese PCI patients based on healthcare information database

Speaker: Doctor H. Yokoi (Fukuoka, JP)


Assessment of cardiovascular disease risk using different thresholds to define high risk on the pooled cohort equations

Speaker: Doctor R. Rosenson (New York, US)


Access the full session

Atrial fibrillation, stroke and cardiovascular risk

Speakers: Doctor E. Kogan, Mrs R. Hamershock, Doctor K. Zint, Doctor V. Mehta, Doctor H. Yokoi...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb